Navigation Links
Cardinal Health Appoints Bruce Downey to Board of Directors; John McCoy Retires From Board After 22 Years

DUBLIN, Ohio, July 2 /PRNewswire-FirstCall/ -- Cardinal Health today announced that Bruce L. Downey will join the company's board of directors effective upon the completion of the planned spinoff of CareFusion Corporation, replacing John B. McCoy who has retired from the board for personal reasons after 22 years of service to the company as a director.

Downey is the former chairman and chief executive officer of Barr Pharmaceuticals, Inc. and past chairman of the Generic Pharmaceutical Association.

"John McCoy has been a committed board member for more than two decades, and we extend our sincere appreciation for the invaluable guidance he has provided during a tenure that helped transform Cardinal Health into the industry leader it is today," said R. Kerry Clark, Cardinal Health chairman and chief executive officer. "John has been part of a tremendous growth story since 1987, and we wish him well in the future."

Downey served from 1994 to 2008 as chairman and chief executive officer of Barr, a global specialty pharmaceutical company that operated in more than 30 countries. During Downey's tenure at Barr, the company grew revenue from $60 million to more than $2.5 billion and became the fourth largest global generic drug company prior to its acquisition by Teva. Prior to joining Barr, Downey was a partner at the law firm of Winston and Strawn. He began his career in the Honors Program of the U.S. Department of Justice. He later worked as a special litigation counsel at the U.S. Department of Energy.

Downey currently serves as the chair of the Board of Ambassadors for Johns Hopkins' Project RESTORE, which funds research and clinical trials to support the creation of progressive treatments for transverse myelitis and multiple sclerosis. He also serves on the board of Momenta Pharmaceuticals and is a partner in NewSpring Health II, a venture capital firm.

"We are thrilled that Bruce will be joining the board of the 'new' Cardinal Health," said George Barrett, future chairman and chief executive officer of Cardinal Health. "Bruce is a dynamic and creative leader who will bring unique perspectives to our company. We look forward to welcoming him to our board following completion of the planned spinoff."

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $91 billion, global company serving the health care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients. With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies, including Alaris(R) IV pumps, Pyxis(R) automated dispensing and patient identification systems, MedMined(TM) electronic infection surveillance service and VIASYS(R) respiratory care products. The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 18 on the Fortune 500, Cardinal Health employs more than 40,000 people on five continents. More information about the company may be found at

SOURCE Cardinal Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Boston Cardinal OMalley Withdraws Caritas Christi From Potential Abortion Scandal
2. Cardinal Health Foundation Awards $1 Million to Fund Patient Safety Initiatives
3. Cardinal Health Investor and Analyst Advisory
4. Cardinal Health Increases Quarterly Dividend By 25 Percent
5. Cardinal George Praises President Obamas Promise to Support Conscience Clauses, Seeks to Work With Administration on Goal
6. Cardinal Health to Offer Allscripts Electronic Health Record to Solo and Small Physician Groups
7. Cardinal Health Board Proposes Employee Stock Option Exchange Program, Declares Regular Quarterly Dividend
8. Cardinal Health Reports Third Quarter Results
9. The Ohio State University, Cardinal Health, State of Ohio to Invest $10 Million to Advance Medical Imaging Industry
10. Cardinal Rigali Praises House Re-Introduction of Pregnant Women Support Act, Urges Co-Sponsorship
11. Cardinal Rigali Criticizes Draft NIH Guidelines for Destructive Stem Cell Research
Post Your Comments:
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: